Maxor COVID-19 Update #3
We are pleased to bring you another update on the COVID-19 pandemic and Maxor’s response. Despite the abrupt disruption to normal […]
We are pleased to bring you another update on the COVID-19 pandemic and Maxor’s response. Despite the abrupt disruption to normal […]
On this April 2, 2020 webinar, Maxor’s Clinical team reviews the latest COVID-19 data and related drug pipeline trends and
As the COVID-19 crisis continues to unfold, we know it is important to keep you updated on our response, perspective,
While these are unprecedented times in many ways – in adversity we find our strength. Over the last few weeks
This is the first communication of a regular publication that Maxor will release related to our Corona virus (COVID-19) perspective
This memo details Maxor’s perspective on the current COVID-19 situation and contingency planning across Maxor’s various business lines, including PBM,